COVID-19: ACE, Targeted Therapies, Old & New Medicines Sachi research featured on KGNU coverage

Updated: Nov 17

Sachi research featured on KGNU Community radio



Sachi founders were featured on KGNU Community radio.


This episode talks about research about COVID-19, angiotensin converting enzyme (ACE), and targeted therapies, and our feature is an interview with scientists Anushree Chatterjee and Prashant Nagpal. This science team explains why there may be a downside to adapting old medications to fight Covid-19. They’ll also explain their anguish about why creating new “drugs” to fight Covid-19 cannot happen as fast as they or anyone would like. They are also developing a way to give people a tiny dose of nanoparticles–basically incredibly tiny microchips, preprogrammed to specifically target a disease such as Covid-19 (see our earlier discussions with them).


Link to the podcast


9 views0 comments

Recent Posts

See All